600332 白云山
已收盘 12-26 15:00:00
资讯
新帖
简况
每周股票复盘：白云山（600332）子公司获狂犬病疫苗注册证
证券之星 · 12-28 05:25
每周股票复盘：白云山（600332）子公司获狂犬病疫苗注册证
白云山最新公告：旗下生物制品公司获冻干人用狂犬病疫苗注册证书
证券之星 · 12-25
白云山最新公告：旗下生物制品公司获冻干人用狂犬病疫苗注册证书
白云山：第九届董事会第三十二次会议决议公告
证券日报 · 12-22
白云山：第九届董事会第三十二次会议决议公告
白云山 - 子公司出资人民币9950万元参与建立GP荔湾基金
美股速递 · 12-22
白云山 - 子公司出资人民币9950万元参与建立GP荔湾基金
白云山 - 参与设立广开基金和荔湾基金
美股速递 · 12-22
白云山 - 参与设立广开基金和荔湾基金
白云山最新公告：附属企业拟投资9750万元认购广药广开基金有限合伙份额
证券之星 · 12-22
白云山最新公告：附属企业拟投资9750万元认购广药广开基金有限合伙份额
白云山 - 旗下单位将以5.005亿人民币收购浙江医药产业100%股权
美股速递 · 12-17
白云山 - 旗下单位将以5.005亿人民币收购浙江医药产业100%股权
白云山（600332）披露控股子公司拟开展应收账款资产证券化业务，12月17日股价上涨0.12%
证券之星 · 12-17
白云山（600332）披露控股子公司拟开展应收账款资产证券化业务，12月17日股价上涨0.12%
白云山最新公告：子公司广州医药拟5.005亿元收购浙江医工100%股权
证券之星 · 12-17
白云山最新公告：子公司广州医药拟5.005亿元收购浙江医工100%股权
小摩减持白云山(00874)11.2万股 每股作价18.581港元
智通财经网 · 12-15
小摩减持白云山(00874)11.2万股 每股作价18.581港元
白云山（600332）披露子公司《药品生产许可证》注销公告，12月15日股价下跌1.31%
中金财经 · 12-15
白云山（600332）披露子公司《药品生产许可证》注销公告，12月15日股价下跌1.31%
白云山子公司星珠药业药品生产许可证被注销
财中社 · 12-15
白云山子公司星珠药业药品生产许可证被注销
12月12日白云山现2笔大宗交易 机构净卖出935.42万元
证券之星 · 12-12
12月12日白云山现2笔大宗交易 机构净卖出935.42万元
因27幢建筑存在违法建设，广州市白云山风景名胜区管理局被罚85万
澎湃新闻 · 12-09
因27幢建筑存在违法建设，广州市白云山风景名胜区管理局被罚85万
白云山（600332）披露召开2025年第三次临时股东会通知，12月08日股价下跌0.46%
证券之星 · 12-08
白云山（600332）披露召开2025年第三次临时股东会通知，12月08日股价下跌0.46%
广药白云山拟推动子公司广州医药开展30亿元应收账款资产证券化业务
中金财经 · 12-07
广药白云山拟推动子公司广州医药开展30亿元应收账款资产证券化业务
小摩增持白云山(00874)22万股 每股作价约18.92港元
智通财经 · 12-05
小摩增持白云山(00874)22万股 每股作价约18.92港元
白云山（600332）披露证券变动月报表，12月01日股价上涨0.35%
证券之星 · 12-01
白云山（600332）披露证券变动月报表，12月01日股价上涨0.35%
盘活应收账款“活水”：白云山30亿ABS落地前奏，首期拟发10亿
财中社 · 12-01
盘活应收账款“活水”：白云山30亿ABS落地前奏，首期拟发10亿
白云山(00874)：广州医药拟开展应收账款资产证券化业务
智通财经 · 12-01
白云山(00874)：广州医药拟开展应收账款资产证券化业务
加载更多
公司概况
公司名称：
广州白云山医药集团股份有限公司
所属行业：
医药制造业
上市日期：
2001-02-06
主营业务：
广州白云山医药集团股份有限公司的主营业务是中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研发、制造与销售；西药、中药和医疗器械的批发、零售和进出口业务；大健康产品的研发、生产与销售；医疗服务、健康管理、养生养老等健康产业投资。公司的主要产品是中成药、化学药。
发行价格：
9.80
{"stockData":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":25.87,"timestamp":1766732400000,"preClose":25.85,"halted":0,"volume":7599885,"delay":0,"changeRate":0.0008,"floatShares":1406000000,"shares":1626000000,"eps":1.837,"marketStatus":"已收盘","change":0.02,"latestTime":"12-26 15:00:00","open":25.86,"high":25.95,"low":25.78,"amount":197000000,"amplitude":0.0066,"askPrice":25.88,"askSize":2116,"bidPrice":25.87,"bidSize":33,"shortable":0,"etf":0,"ttmEps":1.837,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":5,"adr":0,"adjPreClose":25.85,"symbolType":"stock","openAndCloseTimeList":[[1766712600000,1766719800000],[1766725200000,1766732400000]],"highLimit":28.44,"lowLimit":23.27,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1625790949,"isCdr":false,"pbRate":1.11,"roa":"--","peRate":14.082744,"roe":"8.88%","epsLYR":1.744,"committee":-0.64166,"marketValue":42059000000,"turnoverRate":0.0054,"status":0,"hkstockBrief":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":18.3,"timestamp":1766549304003,"preClose":18.44,"halted":0,"volume":2514574,"delay":0,"premium":"-36.22"},"floatMarketCap":36370000000},"requestUrl":"/m/hq/s/600332","defaultTab":"news","newsList":[{"id":"2594247109","title":"每周股票复盘：白云山（600332）子公司获狂犬病疫苗注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247109","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247109?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:25","pubTimestamp":1766870713,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，白云山报收于25.87元，较上周的25.72元上涨0.58%。子公司广州白云山生物制品股份有限公司收到国家药品监督管理局核准签发的冻干人用狂犬病疫苗药品注册证书。该疫苗用于预防狂犬病，注册分类为预防用生物制品，药品批准文号有效期至2030年12月21日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK1606","BK0028","BK0070","BK0096","BK0239","BK0097","BK1191","BK1521","BK0012","600332","BK0196","BK1197","BK1515","159646","BK0175","BK0188","00874"],"gpt_icon":0},{"id":"2594681236","title":"白云山最新公告：旗下生物制品公司获冻干人用狂犬病疫苗注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2594681236","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594681236?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:50","pubTimestamp":1766656209,"startTime":"0","endTime":"0","summary":"白云山(600332.SH)公告称，公司合并报表范围内企业白云山生物收到国家药品监督管理局核准签发的冻干人用狂犬病疫苗（Vero细胞）的《药品注册证书》。该疫苗用于预防狂犬病，白云山生物已投入约2.05亿元研发费用。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500026903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0097","BK1521","BK0028","BK0239","BK0070","BK0188","00874","159646","BK1197","BK0183","BK1606","600332","BK0196","BK1515","BK0096","BK0175","BK1191"],"gpt_icon":0},{"id":"2593343821","title":"白云山：第九届董事会第三十二次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2593343821","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593343821?lang=zh_cn&edition=full","pubTime":"2025-12-22 21:40","pubTimestamp":1766410803,"startTime":"0","endTime":"0","summary":"证券日报网讯12月22日晚间，白云山发布公告称，公司第九届董事会第三十二次会议审议通过《关于本公司2026年度日常关联交易预计数的议案》等多项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512223598566472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0196","BK0239","BK1515","BK0175","BK0183","BK0188","BK0070","00874","BK0012","BK0097","BK1521","BK0096","BK1191","BK1197","BK1606","600332","BK0028"],"gpt_icon":0},{"id":"1102865178","title":"白云山 - 子公司出资人民币9950万元参与建立GP荔湾基金","url":"https://stock-news.laohu8.com/highlight/detail?id=1102865178","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102865178?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:55","pubTimestamp":1766404512,"startTime":"0","endTime":"0","summary":"白云山 - 子公司出资人民币9950万元参与建立GP荔湾基金","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0070","BK0188","BK0097","00874","BK1606","BK0239","BK0096","BK0028","BK0012","BK1515","BK1197","BK1191","BK0175","BK0196","600332","BK1521"],"gpt_icon":0},{"id":"1117819498","title":"白云山 - 参与设立广开基金和荔湾基金","url":"https://stock-news.laohu8.com/highlight/detail?id=1117819498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117819498?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:55","pubTimestamp":1766404511,"startTime":"0","endTime":"0","summary":"白云山 - 参与设立广开基金和荔湾基金","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0097","BK0096","BK0196","BK0175","BK0183","600332","BK0012","BK0028","BK0070","BK0188","BK0239"],"gpt_icon":0},{"id":"2593548484","title":"白云山最新公告：附属企业拟投资9750万元认购广药广开基金有限合伙份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2593548484","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593548484?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:30","pubTimestamp":1766403045,"startTime":"0","endTime":"0","summary":"白云山(600332.SH)公告称，公司附属企业广药二期基金拟投资9750万元认购广药广开基金有限合伙份额，占广药广开基金认缴出资总额的48.75%。广药资本作为执行事务合伙人、基金管理人和普通合伙人认缴出资250万元。公司副董事长程宁女士担任广药资本的董事长，因此本次投资构成关联交易。本次投资不构成重大资产重组。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200026407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","600332","BK0196","BK0183","BK1521","BK0012","BK0097","BK0175","BK0188","BK1515","BK0028","BK1197","BK1191","BK0239","BK1606","BK0096","00874"],"gpt_icon":0},{"id":"1191245448","title":"白云山 - 旗下单位将以5.005亿人民币收购浙江医药产业100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1191245448","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191245448?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:48","pubTimestamp":1765982892,"startTime":"0","endTime":"0","summary":"白云山 - 旗下单位将以5.005亿人民币收购浙江医药产业100%股权","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0097","BK1197","BK0188","BK0239","BK0183","600332","BK0028","BK0196","00874","BK0070","BK1521","BK1191","BK0096","BK1515","BK0012","BK0175","BK1606"],"gpt_icon":0},{"id":"2592916198","title":"白云山（600332）披露控股子公司拟开展应收账款资产证券化业务，12月17日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592916198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592916198?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:42","pubTimestamp":1765982548,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘，白云山报收于25.66元，较前一交易日上涨0.12%，最新总市值为417.18亿元。该股当日开盘25.54元，最高25.7元，最低25.46元，成交额达2.7亿元，换手率为0.75%。近日，广州白云山医药集团股份有限公司发布关于2025年第三次临时股东会会议资料的公告。公告显示，公司拟审议一项重要议案：控股子公司广州医药拟开展应收账款资产证券化业务，融资规模不超过30亿元，期限不超过2年。该事项旨在拓宽融资渠道、优化资金结构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700040340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1606","BK0183","00874","600332","BK0175","BK0188","BK0012","BK0196","BK0096","BK0070","BK1191","BK0239","BK1521","BK1197","BK0028","BK0097"],"gpt_icon":0},{"id":"2592991261","title":"白云山最新公告：子公司广州医药拟5.005亿元收购浙江医工100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2592991261","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592991261?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:19","pubTimestamp":1765970393,"startTime":"0","endTime":"0","summary":"白云山(600332.SH)公告称，公司下属控股子公司广州医药与浙江海正药业签署股权交易合同及补充协议，广州医药拟通过公开摘牌方式受让海正药业所持浙江省医药工业有限公司100%股权，转让价款为5.005亿元。本次收购不构成关联交易，不构成重大资产重组，但需通过中国反垄断审查机构进行经营者集中审查，交易尚存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700031414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0183","BK0196","BK1161","BK0096","BK1515","BK0012","159938","BK0097","00874","BK1574","BK0175","BK1606","BK0070","BK1521","BK0028","BK1197","BK0239","600332","09939","BK1191"],"gpt_icon":0},{"id":"2591648052","title":"小摩减持白云山(00874)11.2万股 每股作价18.581港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591648052","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591648052?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:58","pubTimestamp":1765796294,"startTime":"0","endTime":"0","summary":"减持后最新持股数目约为1969.23万股，最新持股比例为8.95%。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20251215/20251215185837_22361.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251215/20251215185837_22361.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2381873111.SGD","IE00BZ1G4Q59.USD","LU0345769631.USD","LU2430703251.USD","LU1116320737.USD","IE00BYXW3230.USD","LU2023250843.SGD","LU2746668974.SGD","600332","LU0203345920.USD","LU0234572021.USD","LU0170899867.USD","BK4207","BK0239","LU0215105999.USD","LU2756315318.SGD","LU0251132253.USD","LU2746668461.USD","LU1496350171.SGD","IE00BWXC8680.SGD","LU2417539215.USD","LU1496350502.SGD","LU1629891620.HKD","BK0183","LU2237443978.SGD","BK4516","LU2462157665.USD","LU0971096721.USD","BK1191","LU1894683264.USD","LU0942090050.USD","BK1521","LU1894683348.USD","IE00BLSP4239.USD","BK1515","BK4534","LU1988902786.USD","00874","IE00BBT3K403.USD","LU0868494617.USD","LU1551013342.USD","LU2237443622.USD","LU0820561818.USD","LU2552382058.USD","LU1914381329.SGD","BK1606","IE00BDRTCR15.USD","IE00BLSP4452.SGD","LU1244550494.USD","LU1116320901.HKD"],"gpt_icon":0},{"id":"2591610368","title":"白云山（600332）披露子公司《药品生产许可证》注销公告，12月15日股价下跌1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591610368","media":"中金财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591610368?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:19","pubTimestamp":1765793980,"startTime":"0","endTime":"0","summary":"近日，广东省药品监督管理局发布通告，广州白云山医药集团股份有限公司子公司广州白云山星珠药业有限公司的《药品生产许可证》已注销。本次注销原因为星珠药业进行生产经营业务调整，在生产范围为中药饮片的《药品生产许可证》有效期届满后不再申请重新发证。星珠药业2024年中药饮片业务未产生营业收入，本次注销对其生产经营无影响，对公司当期业绩无重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251215/31866395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0175","BK1197","BK1521","BK0196","00874","BK0028","BK0183","BK0070","BK0188","BK1606","BK0012","BK0097","BK0096","BK1515","600332","BK0239","BK1191"],"gpt_icon":0},{"id":"2591611835","title":"白云山子公司星珠药业药品生产许可证被注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2591611835","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591611835?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:32","pubTimestamp":1765787529,"startTime":"0","endTime":"0","summary":"12月15日，白云山（600332/00874）发布公告，子公司广州白云山星珠药业有限公司的《药品生产许可证》已被注销。注销的原因是星珠药业进行生产经营业务调整，决定在中药饮片的《药品生产许可证》有效期届满后不再申请重新发证。星珠药业在2024年中药饮片业务没有产生营业收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512153591732319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0096","BK0028","BK0012","BK0097","BK0196","BK1521","BK1606","BK1191","BK1197","600332","BK1515","BK0188","00874","BK0070","BK0183","BK0239","BK0175"],"gpt_icon":0},{"id":"2590698577","title":"12月12日白云山现2笔大宗交易 机构净卖出935.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590698577","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590698577?lang=zh_cn&edition=full","pubTime":"2025-12-12 17:58","pubTimestamp":1765533503,"startTime":"0","endTime":"0","summary":"证券之星消息，12月12日白云山发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交3594.0手。该股近期无解禁股上市。截至2025年12月12日收盘，白云山(600332)报收于26.03元，上涨1.48%，换手率3.31%，成交量46.49万手，成交额11.93亿元。该股最近90天内共有2家机构给出评级，买入评级2家；过去90天内机构目标均价为34.0。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200029117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["00874","BK1606","BK0196","BK0175","BK0239","BK1197","BK0097","BK0188","BK0183","BK1191","BK0012","BK0028","BK1521","BK0070","BK0096","BK1515","600332"],"gpt_icon":0},{"id":"2590633390","title":"因27幢建筑存在违法建设，广州市白云山风景名胜区管理局被罚85万","url":"https://stock-news.laohu8.com/highlight/detail?id=2590633390","media":"澎湃新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590633390?lang=zh_cn&edition=full","pubTime":"2025-12-09 14:26","pubTimestamp":1765261560,"startTime":"0","endTime":"0","summary":"根据《中华人民共和国城乡规划法》第六十四条、《广东省城乡规划条例》第八十条第一款，广州市越秀区人民政府登峰街道办事处对广州市白云山风景名胜区管理局作出行政处罚，罚款858665.8元。公开资料显示，广州市白云山风景名胜区位于广州市中心，总面积21.8平方公里，是国家5A级旅游景区和国家级风景名胜区。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-12-09/doc-inhaeuni0865731.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-09/doc-inhaeuni0865731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","00874","BK0097","BK0096","BK0196","BK0175","BK0183","BK1197","600332","BK0012","BK1606","BK0028","BK0070","BK0188","BK1515","BK0239","BK1521"],"gpt_icon":0},{"id":"2589393113","title":"白云山（600332）披露召开2025年第三次临时股东会通知，12月08日股价下跌0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589393113","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589393113?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:52","pubTimestamp":1765187552,"startTime":"0","endTime":"0","summary":"截至2025年12月8日收盘，白云山报收于25.82元，较前一交易日下跌0.46%，最新总市值为419.78亿元。该股当日开盘25.96元，最高26.02元，最低25.79元，成交额达2.61亿元，换手率为0.72%。公司近日发布公告称，将于2025年12月30日召开2025年第三次临时股东会，会议采取现场投票与网络投票相结合方式，股权登记日为2025年12月22日。A股股东参会登记时间为2025年12月29日，登记地点为公司董事会秘书室。网络投票将通过上海证券交易所系统进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK1606","BK1191","BK0188","00874","BK0183","BK1521","600332","BK0097","BK0196","BK1197","BK0028","BK0239","BK1515","BK0175","BK0012","BK0070"],"gpt_icon":0},{"id":"2589990878","title":"广药白云山拟推动子公司广州医药开展30亿元应收账款资产证券化业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2589990878","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589990878?lang=zh_cn&edition=full","pubTime":"2025-12-07 10:37","pubTimestamp":1765075079,"startTime":"0","endTime":"0","summary":"中访网数据 广州白云山医药集团股份有限公司于2025年12月5日发布公告，披露两项重要资本运作计划。核心决策之一是，公司董事会已审议通过，其控股子公司广州医药股份有限公司拟开展应收账款资产证券化业务。根据计划，广州医药将作为原始权益人，向专项计划管理人出售其基于药品及医疗器械销售对公立医院等形成的应收账款债权，并以此为基础资产发行总额不超过人民币30亿元的资产支持证券。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251207/31849161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0096","09939","159938","BK1197","BK1606","BK0196","BK1515","BK1574","BK0239","BK0175","BK1161","00874","BK0028","BK0070","BK0012","BK1521","BK1191","BK0097","BK0183","600332","BK0188"],"gpt_icon":0},{"id":"2589899548","title":"小摩增持白云山(00874)22万股 每股作价约18.92港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589899548","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589899548?lang=zh_cn&edition=full","pubTime":"2025-12-05 19:02","pubTimestamp":1764932565,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，12月2日，小摩增持白云山(00874)22万股，每股作价18.9213港元，总金额约为416.27万港元。增持后最新持股数目约为1984.23万股，最新持股比例为9.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0976567544.SGD","IE00BBT3K403.USD","IE00B775SV38.USD","LU0320765646.SGD","LU0820561909.HKD","LU2756315318.SGD","IE00B1XK9C88.USD","LU1670627923.USD","LU0251132253.USD","IE00BKVL7J92.USD","00874","LU0323591593.USD","LU0106261372.USD","LU0267386448.USD","LU1116320737.USD","LU1244550577.SGD","LU1974910355.USD","LU1629891620.HKD","LU2746668461.USD","LU0048584097.USD","LU0215105999.USD","LU1894683348.USD","LU2237443895.HKD","IE00BYXW3230.USD","LU2237443465.HKD","LU0208291251.USD","IE00BDCRKT87.USD","LU0868494708.USD","LU0345769631.USD","LU0320765489.SGD","LU1267930490.SGD","LU2237443622.USD","LU1244550494.USD","LU1548497426.USD","LU1261432733.SGD","LU0345769128.USD","LU1366192091.USD","LU2213496289.HKD","LU2237443978.SGD","LU0149725797.USD","LU2023250843.SGD","BK1197","BK4550","BK4566","LU1894683264.USD","IE00BKDWB100.SGD","LU0820561818.USD","IE00BJTD4V19.USD","LU2054465674.USD","600332"],"gpt_icon":0},{"id":"2588766287","title":"白云山（600332）披露证券变动月报表，12月01日股价上涨0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588766287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588766287?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:50","pubTimestamp":1764600644,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，白云山报收于25.89元，较前一交易日上涨0.35%，最新总市值为420.92亿元。该股当日开盘25.8元，最高25.89元，最低25.73元，成交额达4.18亿元，换手率为1.15%。公司近日发布公告，披露截至2025年11月30日的证券变动月报表。公告显示，广州白云山医药集团股份有限公司普通股H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。H股总数为219,900,000股，A股总数为1,405,890,949股，总注册资本为人民币1,625,790,949元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100037792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600332","BK0096","00874","BK0188","BK1606","BK0028","161027","BK1191","BK0070","BK1521","BK0183","BK0196","BK0097","BK0175","BK1515","BK0239","BK1197","BK0012"],"gpt_icon":0},{"id":"2588279227","title":"盘活应收账款“活水”：白云山30亿ABS落地前奏，首期拟发10亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2588279227","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588279227?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:33","pubTimestamp":1764592410,"startTime":"0","endTime":"0","summary":"12月1日，白云山（600332/00874）发布公告，控股子公司广州医药股份有限公司拟在上海证券交易所申请注册发行不超过30亿元的应收账款资产支持证券（ABS），以盘活存量资产、拓宽融资渠道及优化财务结构。本次专项计划的存续期限不超过2年，拟发行的资产支持证券分为优先级和次级，首期专项计划拟发行规模不超过10亿元。募集资金将用于补充广州医药流动资金或置换债务等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512013579357811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0070","BK0028","BK0097","BK0188","BK0183","BK1521","BK1515","BK1191","BK1606","00874","BK0239","BK0012","BK0096","BK1197","BK0175","BK0196","600332"],"gpt_icon":0},{"id":"2588295477","title":"白云山(00874)：广州医药拟开展应收账款资产证券化业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2588295477","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588295477?lang=zh_cn&edition=full","pubTime":"2025-12-01 18:44","pubTimestamp":1764585862,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山 公布，于2025年12月1日，董事会通过了关于广州医药开展应收账款资产证券化业务的议案。截至本公告日，广州医药尚未就拟进行的本次交易签署任何具有法律约束力的协议。广州医药通过本次交易利用应收账款进行资产证券化，可以将应收账款转变为流动性较高的现金资产，达到盘活资产存量、拓宽融资渠道、优化自身财务结构的目的。从本次交易所得款项拟用于补充广州医药的流动资金或置换债务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK1606","BK0028","BK1515","BK0196","BK0012","00874","BK0097","BK0183","BK0175","BK0188","BK0070","BK1191","BK1197","BK1521","09939","BK1574","600332","159938","BK1161","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766943845949,"stockEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0015},{"period":"3month","weight":0.0193},{"period":"6month","weight":-0.0017},{"period":"1year","weight":-0.072},{"period":"ytd","weight":-0.0616}],"compareEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.1575},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.1826}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州白云山医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2001-02-06","address":"广东省广州市荔湾区沙面北街45号","registeredCapital":"162579万元","survey":" 广州白云山医药集团股份有限公司的主营业务是中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研发、制造与销售；西药、中药和医疗器械的批发、零售和进出口业务；大健康产品的研发、生产与销售；医疗服务、健康管理、养生养老等健康产业投资。公司的主要产品是中成药、化学药。","listedPrice":9.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(600332)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(600332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,600332,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(600332)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(600332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}